1-20 of 28
cyclophosphamide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Management of older Hodgkin lymphoma patients

Andrew M. Evens, Jordan Carter, Kah Poh Loh, Kevin A. David
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 233–242.
https://doi.org/10.1182/hematology.2019000028
Published: 2019
Journal Articles

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

Shannon R. McCurdy, Leo Luznik
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 513–521.
https://doi.org/10.1182/hematology.2019001323
Published: 2019
Journal Articles

Is there a role for immunosuppression in antiphospholipid syndrome?

Ecem Sevim, Rohan Willis, Doruk Erkan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 426–432.
https://doi.org/10.1182/hematology.2019000073
Published: 2019
Journal Articles

Selecting Frontline Therapy for CLL in 2018

Nitin Jain
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 242–247.
https://doi.org/10.1182/asheducation-2018.1.242
Published: 2018
Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.
https://doi.org/10.1182/asheducation-2017.1.329
Published: 2017
Journal Articles

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly

Marco Ruella, Pierre Soubeyran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 432–436.
https://doi.org/10.1182/asheducation-2016.1.432
Published: 2016
Journal Articles

Sequencing of chronic lymphocytic leukemia therapies

Jacqueline C. Barrientos
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 128–136.
https://doi.org/10.1182/asheducation-2016.1.128
Published: 2016
Journal Articles

Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?

Peter W. M. Johnson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 316–322.
https://doi.org/10.1182/asheducation-2016.1.316
Published: 2016
Journal Articles

Use of alternative donors for allogeneic stem cell transplantation

Claudio Anasetti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 220–224.
https://doi.org/10.1182/asheducation-2015.1.220
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange

Paul Coppo, Antoine Froissart
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 637–643.
https://doi.org/10.1182/asheducation-2015.1.637
Published: 2015
Journal Articles

Double-hit lymphomas: current paradigms and novel treatment approaches

Kieron Dunleavy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 107–112.
https://doi.org/10.1182/asheducation-2014.1.107
Published: 2014
Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.
https://doi.org/10.1182/asheducation-2013.1.568
Published: 2013
Journal Articles

Treatment strategies for aggressive lymphomas: what works?

Wyndham H. Wilson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 584–590.
https://doi.org/10.1182/asheducation-2013.1.584
Published: 2013
Journal Articles

Therapeutic challenges in acquired factor VIII deficiency

Peter W. Collins
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 369–374.
https://doi.org/10.1182/asheducation.V2012.1.369.3798356
Published: 2012
Journal Articles

Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment

Peter Hillmen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 104–109.
https://doi.org/10.1182/asheducation-2011.1.104
Published: 2011
Journal Articles

What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?

Emma Scott, Donna Reece
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 205–207.
https://doi.org/10.1182/asheducation-2011.1.205
Published: 2011
Journal Articles

Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia

Stephan Stilgenbauer, Thorsten Zenz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 481–488.
https://doi.org/10.1182/asheducation-2010.1.481
Published: 2010
Journal Articles

The Past: What We Have Learned in the Last Decade

Peter Borchmann, Andreas Engert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 101–107.
https://doi.org/10.1182/asheducation-2010.1.101
Published: 2010
Journal Articles

Aplastic Anemia: First-line Treatment by Immunosuppression and Sibling Marrow Transplantation

Jakob R. Passweg, Judith C.W. Marsh
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 36–42.
https://doi.org/10.1182/asheducation-2010.1.36
Published: 2010